Showing results (211-220 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|August 8, 2018
Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registryNiels P G Hoedemaker, Peter Damman, Jan Paul Ottervanger, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2016
Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysisCharlotte Andersson, Jawdat Abdulla
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2017
Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian settingMax Korman, Torbjørn Wisløff
European Heart Journal. Cardiovascular Pharmacotherapy|June 8, 2018
Adherence to dual antiplatelet therapy with ticagrelor in patients with acute coronary syndromes treated with percutaneous coronary intervention in real life. Results of the REAL-TICA registryUwe Zeymer, Martin Cully, Mathias Hochadel
European Heart Journal. Cardiovascular Pharmacotherapy|June 30, 2020
Adherence to prescribed medications in patients with heart failure: insights from liquid chromatography-tandem mass spectrometry-based urine analysisJoanne Simpson, Colette E Jackson, Caroline Haig, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 30, 2020
Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonistsNa He, Sophie Dell'Aniello, Suodi Zhai, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 4, 2023
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)Eliano Pio Navarese, Antonio Landi, Angelo Oliva, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 13, 2020
Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approachChristina J-Y Lee, Anne Pernille Toft-Petersen, Brice Ozenne, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 17, 2025
Tolerability and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with cardiac amyloidosis: a meta-analysis of observational studiesRenzo Laborante, Stefano Elia, Gianluigi Savarese, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 29, 2025
Clinical outcomes with the use of aspirin vs. clopidogrel as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillationSoohyun Kim, Soyoon Park, Hwajung Kim, et al.
Pageof 53